- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.92 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x GDG: GDP-ALPHA-D-GLUCOSE(Non-covalent)
- 4 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
NHE.2: 9 residues within 4Å:- Chain A: R.385, E.410, F.411
- Chain B: E.176, M.179, R.184, R.214, L.215
- Ligands: EDO.8
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Salt bridges: A:R.385, B:R.214
- Hydrophobic interactions: B:L.215
- Water bridges: B:R.214
NHE.10: 9 residues within 4Å:- Chain A: E.176, M.179, R.184, R.214, L.215
- Chain B: R.385, E.410, F.411
- Ligands: EDO.16
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:L.215
- Water bridges: A:R.214
- Salt bridges: A:R.214, B:R.385
NHE.18: 9 residues within 4Å:- Chain C: R.385, E.410, F.411
- Chain D: E.176, M.179, R.184, R.214, L.215
- Ligands: EDO.24
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:L.215
- Water bridges: D:R.214
- Salt bridges: D:R.214, C:R.385
NHE.26: 9 residues within 4Å:- Chain C: E.176, M.179, R.184, R.214, L.215
- Chain D: R.385, E.410, F.411
- Ligands: EDO.32
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:L.215
- Water bridges: C:R.214
- Salt bridges: C:R.214, D:R.385
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 5 residues within 4Å:- Chain A: Q.299, A.302, R.340, Q.341, H.344
Ligand excluded by PLIPEDO.4: 6 residues within 4Å:- Chain A: A.259, R.265, V.374, C.398, S.400, D.401
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: H.358, Y.359, L.360
- Chain C: N.346, E.351, H.354, P.355
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: E.445, R.448, R.449, R.452
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: W.117, V.121, R.125, M.154, E.186
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: L.201, E.410, T.412, A.416
- Chain B: R.214
- Ligands: NHE.2
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain B: Q.299, A.302, R.340, Q.341, H.344
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain B: A.259, R.265, V.374, C.398, S.400, D.401
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain B: H.358, Y.359, L.360
- Chain D: N.346, E.351, H.354, P.355
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain B: E.445, R.448, R.449, R.452
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain B: W.117, V.121, R.125, M.154, E.186
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: R.214
- Chain B: L.201, E.410, T.412, A.416
- Ligands: NHE.10
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain C: Q.299, A.302, R.340, Q.341, H.344
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain C: A.259, R.265, V.374, C.398, S.400, D.401
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain A: N.346, E.351, H.354, P.355
- Chain C: H.358, Y.359, L.360
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain C: E.445, R.448, R.449, R.452
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain C: W.117, V.121, R.125, M.154, E.186
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain C: L.201, E.410, T.412, A.416
- Chain D: R.214
- Ligands: NHE.18
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain D: Q.299, A.302, R.340, Q.341, H.344
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain D: A.259, R.265, V.374, C.398, S.400, D.401
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain B: N.346, E.351, H.354, P.355
- Chain D: H.358, Y.359, L.360
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain D: E.445, R.448, R.449, R.452
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain D: W.117, V.121, R.125, M.154, E.186
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain C: R.214
- Chain D: L.201, E.410, T.412, A.416
- Ligands: NHE.26
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mendes, V. et al., Mycobacterial OtsA Structures Unveil Substrate Preference Mechanism and Allosteric Regulation by 2-Oxoglutarate and 2-Phosphoglycerate. Mbio (2019)
- Release Date
- 2017-06-21
- Peptides
- Alpha,alpha-trehalose-phosphate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.92 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x GDG: GDP-ALPHA-D-GLUCOSE(Non-covalent)
- 4 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mendes, V. et al., Mycobacterial OtsA Structures Unveil Substrate Preference Mechanism and Allosteric Regulation by 2-Oxoglutarate and 2-Phosphoglycerate. Mbio (2019)
- Release Date
- 2017-06-21
- Peptides
- Alpha,alpha-trehalose-phosphate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A